| Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study SH Culp, PF Schellhammer, MB Williams European urology 65 (6), 1058-1066, 2014 | 489 | 2014 |
| The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus NG Cost, SE Delacroix Jr, JP Sleeper, PJ Smith, RF Youssef, BF Chapin, ... European urology 59 (6), 912-918, 2011 | 229 | 2011 |
| Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? SH Culp, NM Tannir, EJ Abel, V Margulis, P Tamboli, SF Matin, CG Wood Cancer 116 (14), 3378-3388, 2010 | 225 | 2010 |
| Gold nanoparticle coated carbon nanotube ring with enhanced raman scattering and photothermal conversion property for theranostic applications J Song, F Wang, X Yang, B Ning, MG Harp, SH Culp, S Hu, P Huang, ... Journal of the American Chemical Society 138 (22), 7005-7015, 2016 | 221 | 2016 |
| Refining patient selection for neoadjuvant chemotherapy before radical cystectomy SH Culp, RJ Dickstein, HB Grossman, SM Pretzsch, S Porten, ... The Journal of urology 191 (1), 40-47, 2014 | 197 | 2014 |
| Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma EJ Abel, SH Culp, NM Tannir, SF Matin, P Tamboli, E Jonasch, CG Wood European urology 59 (1), 10-15, 2011 | 128 | 2011 |
| Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma BF Chapin, SE Delacroix Jr, SH Culp, GMN Gonzalez, NM Tannir, ... European urology 60 (5), 964-971, 2011 | 110 | 2011 |
| Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence HG Sim, D Telesca, SH Culp, WJ Ellis, PH Lange, LD True, DW Lin The Journal of urology 179 (5), 1775-1779, 2008 | 94 | 2008 |
| Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment EJ Abel, SH Culp, SF Matin, P Tamboli, MJ Wallace, E Jonasch, ... The Journal of urology 184 (5), 1877-1881, 2010 | 88 | 2010 |
| Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases EJ Abel, A Carrasco, SH Culp, SF Matin, P Tamboli, NM Tannir, CG Wood BJU international 110 (11), 1742-1746, 2012 | 81 | 2012 |
| Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib EJ Abel, SH Culp, NM Tannir, P Tamboli, SF Matin, CG Wood European urology 60 (6), 1273-1279, 2011 | 80 | 2011 |
| Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma V Margulis, SF Shariat, Y Rapoport, M Rink, DD Sjoberg, NM Tannir, ... European urology 63 (5), 947-952, 2013 | 77 | 2013 |
| Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy SL Richey, SH Culp, E Jonasch, PG Corn, LC Pagliaro, P Tamboli, ... Annals of oncology 22 (5), 1048-1053, 2011 | 66 | 2011 |
| Universal Lynch syndrome screening should be performed in all upper tract urothelial carcinomas JY Ju, AM Mills, MS Mahadevan, J Fan, SH Culp, MH Thomas, HP Cathro The American journal of surgical pathology 42 (11), 1549-1555, 2018 | 65 | 2018 |
| Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma JA Karam, XY Zhang, P Tamboli, V Margulis, H Wang, EJ Abel, SH Culp, ... European urology 59 (4), 619-628, 2011 | 63 | 2011 |
| The effect of obesity and lower serum prostate‐specific antigen levels on prostate‐cancer screening results in American men S Culp, M Porter BJU international 104 (10), 1457-1461, 2009 | 61 | 2009 |
| Androgen receptor (AR) expression in AR‐negative prostate cancer cells results in differential effects of DHT and IGF‐I on proliferation and AR activity between localized and … SR Plymate, MK Tennant, SH Culp, L Woodke, M Marcelli, I Colman, ... The Prostate 61 (3), 276-290, 2004 | 57 | 2004 |
| Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy AG McIntosh, EC Umbreit, LC Holland, C Gu, NM Tannir, SF Matin, ... Cancer 126 (17), 3950-3960, 2020 | 46 | 2020 |
| Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era SH Culp, JA Karam, CG Wood Urologic Oncology: Seminars and Original Investigations 32 (5), 561-568, 2014 | 42 | 2014 |
| Histologic and immunohistochemical assessment of penile carcinomas in a North American population MJ Mentrikoski, EB Stelow, S Culp, HF Frierson Jr, HP Cathro The American Journal of Surgical Pathology 38 (10), 1340-1348, 2014 | 36 | 2014 |
Ashish M. Kamat, MD, MBBS, FACSProfessor, MD Anderson Cancer CenterVerified email at mdanderson.org
